p63: A novel myoepithelial cell marker in canine mammary tissues

Veterinary Pathology

Volumn 40, Issue 4, 2003, Pages 412-420

  Gama, A ^a   Alves, A ^a   Gartner, F ^b   Schmitt, F ^b,c  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

Author keywords

Dogs; Immunohistochemistry; Mammary gland; Myoepithelial cell; p63

Indexed keywords

ALPHA ACTIN; BIOLOGICAL MARKER; CYTOKERATIN 14; MONOCLONAL ANTIBODY; PROTEIN P53; PROTEIN P63; VIMENTIN; CKAP4 PROTEIN, HUMAN; MEMBRANE PROTEIN; PHOSPHOPROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL TISSUE; ARTICLE; BENIGN TUMOR; BREAST; CARCINOSARCOMA; CELL COMPARTMENTALIZATION; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOG; HISTOGENESIS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALIGNANT NEOPLASTIC DISEASE; MYOEPITHELIUM CELL; NEOPLASM; NONHUMAN; OSTEOSARCOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY; SOLID TUMOR; TISSUE DISTRIBUTION; ANIMAL; ANIMAL DISEASE; CYTOLOGY; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; METABOLISM; MYOEPITHELIOMA; PATHOLOGY; UDDER;

ANIMALIA; CANIS FAMILIARIS;

ANIMALS; BIOLOGICAL MARKERS; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MEMBRANE PROTEINS; MYOEPITHELIOMA; PHOSPHOPROTEINS; TRANS-ACTIVATORS;

EID: 0141923558     PISSN: 03009858     EISSN: None     Source Type: Journal    
DOI: 10.1354/vp.40-4-412     Document Type: Article

References (37)

1. Barbareschi M, Pecciarini L, Cangi MG, Macri E, Rizzo A, Viale G, Doglioni C: p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 25:1054-1060, 2001
2. de Laurenzi V, Melino G: Evolution of functions within the p53/p63/p73. Ann N Y Acad Sci 926:90-100, 2000
3. Destexhe E, Lespagnard L, Degeyter M, Heymann R, Coignoul F: Immunohistochemical identification of myoepithelial, epithelial, and connective tissue cells in canine mammary tumors. Vet Pathol 30:146-154, 1993
4. Deugnier M-A, Moiseyeva EP, Thiery JP, Glukhova M: Myoepithelial cell differentiation in the developing mammary gland: progressive acquisition of smooth muscle phenotype. Dev Dyn 204:107-117, 1995
5. Espinosa de Los Monteros A, Millán MY, Ordás J, Carrasco L, Reymundo C, Martín de Las Mulas J: Immunolocalization of the smooth muscle-specific protein calponin in complex and mixed tumors of the mammary gland of the dog: assessment of the morphogenetic role of the myoepithelium. Vet Pathol 39:247-256, 2002
6. Ferguson HR: Canine mammary gland tumours. Vet Clin North Am Small Anim Pract 15:501-511, 1985
7. Foschini MP, Scarpellini F, Gown AM, Eusebi V: Differential expression of myoepithelial markers in salivary, sweat and mammary glands. Int J Surg Pathol 8:29-37, 2000
8. Fowler EH, Wilson GP, Koestner A: Biologic behavior of canine mammary neoplasms based on a histogenetic classification. Vet Pathol 11:212-229, 1974
9. Gartner F, Geraldes M, Cassali G, Rema A, Schmitt F: DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed tumours: putative evidence for a common histogenesis. Vet J 158:39-47, 1999
10. Griffey SM, Madewell BR, Dairkee SH, Hunt JE, Naydan DK, Higgins RJ: Immunohistochemical reactivity of basal and luminal epithelium-specific cytokeratin antibodies within normal and neoplastic canine mammary glands. Vet Pathol 30:155-161, 1993
11. Gusterson BA, Warburton MJ, Mitchell D, Ellison M, Neville AM, Rudland PS: Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res 42:4763-4770, 1982
12. Hampe JF, Misdorp W: Tumours and displasias of the mammary gland. Bull World Health Organ 50:111-133, 1974
13. Hellmen E, Lindgren A: The expression of intermediate filaments in canine mammary glands and their tumors. Vet Pathol 26:420-428, 1989
14. Kaelin WGJ: The emerging p53 gene family. J Natl Cancer Inst 91:594-598, 1999
15. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE: Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 90:999-1003, 1993
16. Little NA, Jochemsen AG: p63. Int J Biochem Cell Biol 34:6-9, 2002
17. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A: p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713, 1999
18. Misdorp W, Else W, Hellmen E, Lipscomb TP: Histological classification of the mammary tumors of the dog and the cat. In: World Health Organization International Histological Classification of Tumors of Domestic Animals, ed. Schulman FY, 2nd series, vol. 7, pp. 1-59. AFIP, Washington, DC, 1999
19. Moulton JE. Tumors of the mammary gland. In: Tumors in Domestic Animals, ed. Moulton JE, 3rd ed., pp. 518-553. University of California Press, Berkeley, CA, 1990
20. Nerurkar VR, Chitale AR, Jalnakurpar BV, Naik SN, Lalitha VS: Comparative pathology of canine mammary tumours. J Comp Pathol 101:389-397, 1989
21. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M: p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 98:3156-3161, 2001
22. Petersen OW, Nielsen HL, Gudjonsson T, Villadesn R, Ronnov-Jessen L, Bissel, MJ: The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion. Breast Cancer Res 3:213-217, 2001
23. Rabanal RM, Else RW: Immunohistochemical localisation of cytokeratin and vimentin intermediate filament proteins in canine mammary tumours. Res Vet Sci 56:225-233, 1994
24. Reis-Filho JS, Schmitt FC: Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol 9:280-289, 2002
25. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC: p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 29:517-523, 2002
26. Rudland PS, Hughes CM: Immunohistochemical identification of cell types in human mammary gland: variation in cellular markers are dependent on glandular topography and differentiation. J Histochem Cytochem 37:1087-1100, 1989
27. Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L, Yang A, Montironi R, McKeon F, Loda M: p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 157:1764-1775, 2000
28. Tateyama S, Cotchin E: Alkaline phosphatase reaction of canine mammary mixed tumours: a light and electron microscopic study. Res Vet Sci 23:356-364, 1977
29. Tateyama S, Cotchin E: Electron microscopic observations on canine mixed mammary tumours, with special reference to cytoplasmic filamentous components. Am J Vet Res 39:1494-1501, 1978
30. Tateyama S, Uchida K, Hidaka T, Hirao M, Yamaguchi R: Expression of bone morphogenetic protein-6 (BMP-6) in myoepithelial cells in canine mammary gland tumors. Vet Pathol 38:703-709, 2001
31. Tsubura A, Hatano T, Hayama S, Morii S: Immunophenotypic difference of keratin expression in normal mammary glandular cells from five different species. Acta Anat 140:287-293, 1991
32. Vos JH, Van den Ingh TS, Misdorp W, Molenbeek RF, Van Mil FN, Rutterman GR, Ivanyi D, Ramaekers FCS: Immunohistochemistry with keratin, vimentin, desmin, and α-smooth muscle actin monoclonal antibodies in canine mammary gland: benign mammary tumors and duct ectasias. Vet Q 14:89-95, 1993
33. Vos JH, Van den Ingh TS, Misdorp W, Molenbeek RF, Van Mil FN, Rutterman GR, Ivanyi D, Ramaekers FCS: Immunohistochemistry with keratin, vimentin, desmin, and α-smooth muscle actin monoclonal antibodies in canine mammary gland: malignant mammary tumors. Vet Q 14:96-102, 1993
34. Vos JH, Van den Ingh TS, Misdorp W, Molenbeek RF, Van Mil FN, Rutterman GR, Ivanyi D, Ramaekers FCS: Immunohistochemistry with keratin, vimentin, desmin, and α-smooth muscle actin monoclonal antibodies in canine mammary gland: normal mammary tissue. Vet Q 14:102-107, 1993
35. Yang A, Kaghad M, Wang Y, Gillet E, Fleming MD, Dotsch V, Andrews NC, Caput D, Mc Keon F: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing and dominant-negative activities. Mol Cells 2:305-316, 1998
36. Yang A, Mc Keon F: p63 and p73: p53 mimics, menaces and more. Nat Rev Mol Cell Biol 1:194-207, 2000
37. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, Mc Keon F: p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714-718, 1999